Northwest Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 13, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	383	364	822	830	663	1,255
Market Cap Growth	0.97%	-55.72%	-1.00%	25.14%	-47.13%	870.89%
Enterprise Value	469	435	881	865	686	1,270
Last Close Price	0.24	0.27	0.70	0.78	0.70	1.52
PE Ratio	-	-	-	-	3.70	-
PS Ratio	408.77	263.35	425.38	493.23	660.04	971.84
PB Ratio	-4.02	-4.61	-17.47	-7.90	-5.35	-3.46
EV/Sales Ratio	-	314.92	455.93	513.96	682.10	983.37
Debt / Equity Ratio	-0.81	-0.85	-0.97	-0.25	-0.31	-0.05
Asset Turnover	0.03	0.05	0.07	0.05	0.03	0.06
Quick Ratio	0.05	0.03	0.05	0.06	0.11	0.03
Current Ratio	0.08	0.06	0.09	0.08	0.13	0.04
Return on Assets (ROA)	-135.38%	-152.28%	-117.23%	-117.48%	-90.17%	-248.63%
Return on Capital Employed (ROCE)	113.30%	160.10%	320.10%	71.00%	56.30%	24.80%
Earnings Yield	-23.82%	-23.02%	-7.62%	-12.65%	27.00%	-42.23%
FCF Yield	-13.28%	-15.95%	-6.94%	-6.71%	-6.68%	-3.08%
Buyback Yield / Dilution	-16.16%	-10.99%	-10.17%	-0.79%	-38.99%	-28.53%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.